# Definium Therapeutics, Inc.: Form 8-K/A, filed Sep 15, 2023

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K/A
- Filed: 2023-09-15
- Accepted by EDGAR: Sep 15, 2023, 17:27 ET
- Period: 2023-08-14
- Accession: 0000950170-23-048432
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000095017023048432/mnmd-20230814.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000095017023048432/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000095017023048432/mnmd-20230814.htm

Filed Sep 15, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-048432. Last ingested by Listed: Nov 10, 2026, 02:38 ET. No prices; not investment advice.